Form 2 of AZD5718 tablets: Clinical Trials

1 trial of Form 2 of AZD5718 tablets, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Form 2 of AZD5718 tablets: new trials by email Literature Review of Form 2 of AZD5718 tablets trials Research Report on Form 2 of AZD5718 tablets

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy Volunteers
Form 1 of AZD5718 tablets, Form 2 of AZD5718 tablets, Form 3 of AZD5718 tablets - Coronary Artery Disease
Phase 1CompletedAstraZeneca142018-02-052018-04-23

Conditions studied

Coronary Artery Disease (1)

Sponsors

AstraZeneca (1)

Countries

United Kingdom (1)

Top investigators

Pablo Forte Soto, MD (1)